Skip to content
← Full study record

NCT02037256 · MORE INFO

Limitations, agreements, and source contact

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma · Source last updated 2021-05-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
db3203@cumc.columbia.edu
organization
Barbara Ann Karmanos Cancer Institute
phone
501-680-9229
title
Dr. Divaya Bhutani
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
db3203@cumc.columbia.edu
organization
Barbara Ann Karmanos Cancer Institute
phone
501-680-9229
title
Dr. Divaya Bhutani

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice